Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details
Completed

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05024045

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 23 locations
View Trial Details
Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

NCT03570892

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
View all 67 locations
View Trial Details

Related conditions